Microplate systems market to reach $2.36 billion by 2030

The Business Research Company says the global microplate systems market grew to $1.57 billion in 2026 and is projected to hit $2.36 billion by 2030, driven by rising R&D spending, lab automation and broader use in drug screening. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Microplate systems sit at the center of drug discovery, diagnostics and life sciences research. - Faster growth in this market signals rising demand for higher-throughput lab tools and more automated workflows. - The market’s expansion also tracks with broader investment in biotechnology, genomics and personalized medicine.

What happened: - The Business Research Company released its Microplate Systems Market Report 2026, covering market size, trends and a global forecast through 2035. - The report says the market rose from $1.42 billion in 2025 to $1.57 billion in 2026. - The report projects the market will reach $2.36 billion by 2030. - The report identifies North America as the largest regional market in 2025. - The report names Asia-Pacific as the fastest-growing region over the forecast period. - The report includes coverage of South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available. - A full market report is also available.

The details: - Microplate systems are laboratory instruments used to detect and measure biological, chemical or physical events using microplate formats. - The systems are used in biotechnology, pharmaceuticals and clinical diagnostics. - The report says recent growth was driven by pharmaceutical R&D spending, biotechnology research, microplate use in drug screening, chronic disease prevalence and academic life science studies. - The report projects faster growth ahead, supported by assay technology innovation, personalized medicine, contract research organizations, laboratory automation, and genomics and proteomics research. - The report highlights trends including high-throughput screening in drug discovery, multi-mode microplate readers, greater automation in lab workflows, expanded clinical diagnostic use and miniaturized high-density microplate formats. - The report says the market grew at a 10.9% CAGR from 2025 to 2026. - The report projects a 10.6% CAGR from 2026 to 2030. - The report says microplate systems speed up drug discovery by enabling simultaneous testing of thousands of compounds. - The report says automation in liquid handling and data analysis improves accuracy, reproducibility and research timelines while reducing costs. - IQVIA reported in January 2024 that global medicine usage rose 14% over the prior five years and is projected to rise another 12% by 2028 to 3.8 trillion defined daily doses annually.

Between the lines: - The report points to a market moving from broad research use toward more automated, higher-density and clinically relevant applications. - Growth in contract research organizations and lab automation suggests more outsourced and scaled-up testing demand. - The regional split suggests North American demand remains strongest, but investment momentum is shifting toward Asia-Pacific. - The company’s expanded 2026 report features market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

What's next: - The Business Research Company expects growth to continue through 2030 as assay technologies, personalization and automation reshape lab workflows. - The report says high-throughput screening and multi-mode readers will remain important product themes. - Continued investment in life sciences infrastructure in Asia-Pacific could accelerate regional market share gains.

The bottom line: - Microplate systems are becoming more important as labs push for faster, more automated and more precise testing across research and diagnostics.